ACP Journal Club.  Telmisartan did not reduce a composite of   CV death, MI, HF, or stroke in high-risk   patients intolerant to ACE inhibitors.
Taylor
Robin J
RJ
Queen Elizabeth Hospital, Gateshead, Newcastle, England, UK.